Mastodon

Kashlex (Solution) Instructions for Use

Marketing Authorization Holder

Genel RD, LLC (Russia)

Manufactured By

Samaramedprom, OJSC (Russia)

ATC Code

R05CA (Expectorants)

Active Substance

Hederae Helix folia (Grouping name)

Dosage Form

Bottle OTC Icon Kashlex Oral solution: 50 ml, 100 ml, 120 ml, 150 ml, or 200 ml bottle

Dosage Form, Packaging, and Composition

Oral solution in the form of a rather thick liquid from yellow to yellow-brown in color, with a characteristic odor; the presence of opalescence during storage is allowed.

100 ml
Hedera helix leaf extract* 0.8 g

* Hedera helix leaf extract (Hedera helix leaf thick extract (2.2-2.9:1)) is produced from Hedera helix L., family Araliaceae, by extraction with a mixture of 50% ethanol (ethyl alcohol) and propylene glycol (98:2).

Excipients: macrogol glycerol hydroxystearate (polyoxyl 40 hydrogenated castor oil), anise fruit oil, hyetellose (hydroxyethylcellulose), sorbitol solution 70% (non-crystallizing), propylene glycol, glycerol, purified water.

50 ml – glass bottles (1) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
120 ml – glass bottles (1) – cardboard packs.
150 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (1) – cardboard packs.
100 ml – polymer bottles (1) – cardboard packs.
200 ml – polymer bottles (1) – cardboard packs.

The bottles may be equipped with a measuring cup or a measuring spoon.

Clinical-Pharmacological Group

Herbal expectorant

Pharmacotherapeutic Group

Drugs used for cough and colds; expectorants, excluding combinations with antitussives; expectorants

Pharmacological Action

Herbal medicine. It has an expectorant, mucolytic, and antispasmodic effect, due to the presence of saponins.

Indications

As an expectorant in the complex therapy of infectious and inflammatory diseases of the respiratory tract, accompanied by cough with difficult-to-discharge sputum.

ICD codes

ICD-10 code Indication
J04 Acute laryngitis and tracheitis
J06.9 Acute upper respiratory infection, unspecified
J15 Bacterial pneumonia, not elsewhere classified
J20 Acute bronchitis
J37 Chronic laryngitis and laryngotracheitis
J42 Unspecified chronic bronchitis
R05 Cough
R09.3 Sputum
ICD-11 code Indication
CA05 Acute laryngitis or tracheitis
CA07.0 Acute upper respiratory tract infection of unspecified site
CA0G Chronic laryngitis or laryngotracheitis
CA20.1Z Chronic bronchitis, unspecified
CA40.0Z Bacterial pneumonia, unspecified
CA42.Z Acute bronchitis, unspecified
MD10 Abnormal sputum
MD12 Cough

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally. Shake the bottle well before each use.

Use the provided measuring cup or spoon for accurate dosing. Do not use household spoons.

For adults and adolescents over 12 years: take 5 ml three times daily.

For children 6 to 12 years: take 2.5 ml three times daily.

For children 2 to 5 years: take 2.5 ml twice daily.

The duration of treatment is typically 7 days.

Do not exceed the recommended daily dose.

Take the solution between meals for optimal effect.

If symptoms persist beyond one week or worsen, discontinue use and consult a physician.

Concomitant intake of sufficient warm fluids is recommended to enhance the expectorant effect.

Avoid concurrent use with antitussive medications.

Adverse Reactions

Possible allergic reactions, nausea, vomiting, diarrhea.

Rarely pain in the epigastric region.

Contraindications

Hypersensitivity to the drug; children’s age – depending on the dosage form.

Use in Pregnancy and Lactation

Not recommended for use during pregnancy and lactation.

Pediatric Use

Can be used in children of the appropriate age categories according to the indications, in the recommended doses and dosage forms. It is necessary to strictly follow the instructions in the instructions for Hedera helix preparations regarding contraindications for the use in children of different ages of specific dosage forms of this drug.

Special Precautions

During treatment, it is recommended to consume a sufficient amount of warm fluids (water, tea, etc.).

If there is no effect during treatment with the drug for 5-7 days and/or if the condition worsens (appearance of asthma attacks, purulent sputum, fever), it is necessary to consult a doctor.

Drug Interactions

Should not be used simultaneously with antitussive drugs, as this impedes the discharge of liquefied sputum.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS